Neoadjuvant SHR-1701 with or without chemotherapy in unresectable stage III non-small-cell lung cancer: A proof-of-concept, phase 2 trial
Authors:
Top Cited Papers
Open Access
- 20 June 2024
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 42 (7) , 1258-1267.e2
Abstract
No abstract availableKeywords
Funding Information
- Jiangsu Hengrui Pharmaceuticals Co Ltd
This publication has 46 references indexed in Scilit:
- Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung CancerJAMA, 2024
- LBA1 CheckMate 77T: Phase III study comparing neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) vs neoadjuvant placebo plus chemo followed by surgery and adjuvant NIVO or placebo for previously untreated, resectable stage II–IIIb NSCLCAnnals of Oncology, 2023
- Immunotherapy in unresectable stage III non-small-cell lung cancer: state of the art and novel therapeutic approachesAnnals of Oncology, 2022
- Anti‐PD‐L1/TGF‐βR fusion protein (SHR‐1701) overcomes disrupted lymphocyte recovery‐induced resistance to PD‐1/PD‐L1 inhibitors in lung cancerCancer Communications, 2022
- Dual inhibition of TGF‐β and PD‐L1: a novel approach to cancer treatmentMolecular Oncology, 2021
- 1278P SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF-β, as first-line therapy for PD-L1+ advanced/metastatic NSCLC: Data from a clinical expansion cohort of a phase I studyAnnals of Oncology, 2021
- Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non–Small Cell Lung CancerJAMA Oncology, 2021
- IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant TherapyJournal of Thoracic Oncology, 2020
- Phase II Trial of Concurrent Atezolizumab With Chemoradiation for Unresectable NSCLCJournal of Thoracic Oncology, 2020
- The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung CancerJournal of Thoracic Oncology, 2016